Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.10989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Xiaojun Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
This study aimed to investigate the prognostic value of the Naples Prognostic Score (NPS) in patients with locally advanced cervical cancer (LACC) who received curative concurrent chemoradiotherapy (CCRT). Clinicopathological data from 213 (training set) and 106 (validation set) LACC cases undergoing CCRT were retrospectively analyzed. The receiver operating characteristic curve (ROC) was used to compare the predictive ability of NPS and other indicators for survival. Cox proportional hazard regression was conducted for overall survival (OS) and progression-free survival (PFS). A prediction model using a nomogram was developed with independent prognostic factors in the training set and validated in the validation set. The 5-year OS for the NPS = 1, 2, and 3 groups was 56.8%, 45.4%, and 28.9% (P < 0.001), and the 5-year PFS for the NPS = 1, 2, and 3 groups was 44.9%, 36.7%, and 28.4% (P = 0.001), respectively. NPS showed better predictive ability for OS and PFS compared to other indicators. Multivariate regression analysis identified NPS as an independent prognostic factor for OS (P < 0.001) and PFS (P < 0.001). A predictive nomogram based on NPS was established and validated. The C-indices of the nomogram in the training set were 0.722 for OS and 0.683 for PFS, while in the validation set the C-indices were 0.731 for OS and 0.693 for PFS. This study confirmed that preoperative NPS could serve as a useful independent prognostic factor in LACC patients treated with CCRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, China.
- Wuxi School of Medicine, Jiangnan University, Wuxi, China.
- Department of Rehabilitation Medical, Suzhou Rehabilitation Hospital (Suzhou Municipal Hospital Rehabilitation Medical Center), Suzhou, China.
- Department of Radiotherapy and Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, China.
Zitieren
APA
Zhang, X., Gu, M., Zhu, J., Gu, R., Yang, B., Ji, S., Zhao, Y., & Gu, K. (2024). Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10989
Vancouver
Zhang X, Gu M, Zhu J, Gu R, Yang B, Ji S, et al. Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10989
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaojun and Gu, Mengxuan and Zhu, Jiahao and Gu, Ruike and Yang, Bo and Ji, Shengjun and Zhao, Yutian and Gu, Ke},
title = {Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.10989}
}
EUVIMED